Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1568-2026

Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use Recall

Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use

FDA recall Class I

Ongoing

FDA lists this Class I recall for Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1568-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Feb 12, 2026
FDA report date
Apr 1, 2026
Quantity in commerce
3603 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use

Affected model & UDI checker

Search the exact identifiers published for Z-1568-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
20402-411Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical useCheck source noticeNot specified
Not specifiedFlexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical useCheck source notice04050147021846
FDA code information

UDI: 04050147021846/ Expanded Lots:WO472498 WO472499 WO472615 WO472616 WO473794 WO473795 WO474908 WO474909 WO474910 WO475357 WO475358 WO477030 WO477513 WO477514 WO478643 WO478646 WO478647 WO478648 WO478843 WO478844;Initial Lots: WO461840 WO461846 WO462097 W2462284 WO463327 WO463328 WO463388 W2463594 WO464285 WO464286 WO465063 WO465064 W4465351 W2465601 W2465689 W2465749 W2465769 WO467873 WO467874 WO467875 WO468648 WO468649 WO469364 W2459861 W2459862 W2459863

View the original FDA recall notice

Why was this product recalled?

Probes may rupture/burst during activation

What actions did Erbe USA Inc take?

On May 5, 2026, ERBE USA issued a "Urgent Medical Device Recall Expansion notification via E-Mail. The expansion was issued due to new lot numbers that may cause the same failure mode. The original notification was issued on Feb. 12, 2026. ERBE asked consignees to take the following actions: 1. Discontinue use of the products with the affected lot numbers. 2. Examine your inventory, remove, and quarantine any identified devices with the affected lot numbers 3. Ensure all applicable personnel within the vicinity of device activation carefully read the content of this notification. If affected product has been transferred to a different location, please ensure that location and personnel receive a copy of this notification. 4. Please contact Erbe at fieldaction.us@erbegroup.com or 678-483-8499, to obtain a Return Material Authorization number 5. Please complete the Response Form and return to Erbe 6. If you have further distributed this product, identify your locations, and forward this notification to them. 7. Erbe requests you to report any complaints, including any instances of ruptures/bursts, to our Technical Service Department at 770-955-4400. Adverse events experienced with the use of this product may also be reported to the FDA s MedWatch Adverse Event Reporting program.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology